Amphastar Pharmaceuticals Inc [AMPH] stock is trading at $46.52, up 3.22%. An important factor to consider is whether the stock is rising or falling in short-term value. The AMPH shares have gain 2.42% over the last week, with a monthly amount glided 6.80%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on March 05, 2024, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $60. Previously, BofA Securities started tracking the stock with Neutral rating on November 17, 2023, and set its price target to $63. CapitalOne initiated its recommendation with a Overweight and recommended $44 as its price target on July 29, 2022. Piper Sandler upgraded its rating to Overweight for this stock on January 07, 2022, and upped its price target to $28. In a note dated January 08, 2021, Wells Fargo downgraded an Equal Weight rating on this stock but restated the target price of $21.
Amphastar Pharmaceuticals Inc [AMPH] stock has fluctuated between $36.56 and $65.92 over the past year. Currently, Wall Street analysts expect the stock to reach $66 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $46.52 at the most recent close of the market. An investor can expect a potential return of 41.87% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] reported sales of 712.89M for the trailing twelve months, which represents a growth of 25.17%. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at 0.32%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.25 and Total Capital is 0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.26 points at the first support level, and at 44.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 47.26, and for the 2nd resistance point, it is at 48.01.
Ratios To Look Out For
For context, Amphastar Pharmaceuticals Inc’s Current Ratio is 3.52. On the other hand, the Quick Ratio is 2.63, and the Cash Ratio is 1.39. Considering the valuation of this stock, the price to sales ratio is 3.18, the price to book ratio is 3.19 and price to earnings (TTM) ratio is 14.82.
Transactions by insiders
Recent insider trading involved Petersen Floyd F., Director, that happened on Sep 05 ’24 when 3000.0 shares were sold. Director, Floyd Petersen completed a deal on Sep 05 ’24 to buy 5000.0 shares. Meanwhile, SENIOR EVP, PRODUCTION CENTER Zhou Rong sold 4000.0 shares on Aug 26 ’24.
